Home › Funds › UBS Group AG › NDRA
UBS Group AG position in NDRA
ENDRA LIFE SCIENCES INC · Health Care
Latest position (Q2 2026)68 sh
Reported value held$362
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 28.21K | $49.00K | New |
| Q4 2021 | 28.20K | $19.00K | Hold |
| Q1 2022 | 28.20K | $11.00K | Hold |
| Q2 2022 | 40.13K | $9.00K | Add |
| Q4 2022 | 2.15K | $8.75K | New |
| Q1 2024 | 140 | $81 | New |
| Q2 2024 | 55.45K | $5.38K | Add |
| Q4 2024 | 95 | $595 | New |
| Q2 2025 | 4.70K | $16.48K | New |
| Q3 2025 | 106 | $570 | Reduce |
| Q4 2025 | 12 | $54 | Reduce |
| Q1 2026 | 152 | $707 | Add |
| Q2 2026 | 68 | $362 | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding NDRA
- Citadel Advisors 29.92K sh · $159.50K · Q2 2026
- Geode Capital Management 14.91K sh · $79.47K · Q2 2026
- Vanguard Group 12.94K sh · $58.60K · Q4 2025
- Morgan Stanley 3.55K sh · $18.90K · Q2 2026